Patrick J. Heron, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 290,702 shares at $68.48 ($9.0M) on 2026-01-23, disclosed to the SEC on 2026-01-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 159,277 | $0 | 0.0% |
| 2 | $68.48 | 131,425 | $9.0M | 100.0% |
| Total | $30.96 avg | 290,702 | $9.0M | 100% |
| Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |
| ARQT | BUY | 2025-05-15 | $119K | — | Filing → |